Ordenar

Buscar

01/08/2025 Low type-2 immune effectors modulate atopic diseases' protective role in pancreatic cancer risk
He, JC, Alhamwe, BA, Sabroso, S, Carrato, A, Hidalgo, M, Molero, X, Iglesias, M, Perea, J, Farré, A, Tardón, A, Dominguez-Muñoz, E, Barberà, V, Muñoz-Bellvís, L, Löhr, M, Greenhalf, W, O'Rorke, M, Gress, T, Crnogorac-Jurcevic, T, Gayà, A, Langtry, A, Kleeff, J, Lawlor, R, Real, FX, Renz, H, Malats, N, PanGenEU Study Investigators. Low type-2 immune effectors modulate atopic diseases' protective role in pancreatic cancer risk. INTERNATIONAL JOURNAL OF CANCER. 2025; 157(3)DOI:10.1002/ijc.35397. PMID:40098454. IF:4.700(Q1/3D).
01/08/2025 Impaired cerebrospinal fluid lipoprotein-mediated cholesterol transport in Alzheimer's disease
Querol, CB, Canyelles, M, Santos, D, Martínez, J, Mercer, A, Zhao, Q, Rotllan, N, Núñez, E, Vázquez, J, Maspoch, D, Cano-Sarabia, M, Carmona-Iragui, M, Sirisi, S, Lleó, A, Fortea, J, Alcolea, D, Blanco-Vaca, F, Escolà-Gil, JC, Tondo, M. Impaired cerebrospinal fluid lipoprotein-mediated cholesterol transport in Alzheimer's disease. ATHEROSCLEROSIS. 2025; 407DOI:. PMID:. IF:5.700(Q1/1D).
01/08/2025 Cerebrospinal fluid lipoprotein-mediated cholesterol delivery to neurons is impaired in Alzheimer's disease and involves APOE4
Borràs, C, Canyelles, M, Santos, D, Rotllan, N, Núñez, E, Vàzquez, J, Maspoch, D, Cano-Sarabia, M, Zhao, Q, Carmona-Iragui, M, Sirisi, S, Lleó, A, Fortea, J, Alcolea, D, Blanco-Vaca, F, Escolà-Gil, JC, Tondo, M. Cerebrospinal fluid lipoprotein-mediated cholesterol delivery to neurons is impaired in Alzheimer's disease and involves APOE4. JOURNAL OF LIPID RESEARCH. 2025; 66(8)DOI:10.1016/j.jlr.2025.100865. PMID:40701521. IF:4.100(Q2/4D).
01/08/2025 Genetic architecture of FTLD-TDP pathological subtypes
Dols-Icardo, O, Reus, LM, Ramirez, A. Genetic architecture of FTLD-TDP pathological subtypes. TRENDS IN NEUROSCIENCES. 2025; 48(8)DOI:10.1016/j.tins.2025.06.005. PMID:40610249. IF:15.100(Q1/1D).
01/08/2025 Maintaining kidney health in aging societies: a JSN and ERA call to action
Ortiz, A, Kramer, A, Rychlík, I, Nangaku, M, Yanagita, M, Jager, KJ, Caskey, FJ, Stel, VS, Kashihara, N, Kuragano, T, Suzuki, Y, Takemoto, Y, Yokoi, H, Palladino, G, Fliser, D, Torra, R, Wanner, C. Maintaining kidney health in aging societies: a JSN and ERA call to action. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2025; 40(8)DOI:10.1093/ndt/gfaf068. PMID:40210592. IF:5.600(Q1/1D).
01/08/2025 Phenotypic variability in cystinosis: Lessons from an atypical case
Toso, D, Furlano, M, Tinoco, A, Saltor, TS, Ars, E, Torra, R. Phenotypic variability in cystinosis: Lessons from an atypical case. NEFROLOGIA. 2025; 45(7)DOI:10.1016/j.nefro.2025.501342. PMID:. IF:2.600(Q2/4D).
01/08/2025 Pretransplant Clusters and Outcomes Determining Variables of Expanded Criteria Donors Controlled Donation After Circulatory Death Kidney Transplants through a Hybrid Artificial Intelligence-Based Model Combining Survival Analysis, Multiple Criteria Optimization and an Artificial Neural Network
Santos-Arteaga, F, Di Caprio, D, Montero, N, Toapanda, N, Crespo, M, Facundo, C, Melilli, E, Cucchiari, D, Moreso, F, Anna, B, Perich, LG, Diekmann, F, Cruzado, J, Bestard, O, Revuelta, I. Pretransplant Clusters and Outcomes Determining Variables of Expanded Criteria Donors Controlled Donation After Circulatory Death Kidney Transplants through a Hybrid Artificial Intelligence-Based Model Combining Survival Analysis, Multiple Criteria Optimization and an Artificial Neural Network. AMERICAN JOURNAL OF TRANSPLANTATION. 2025; 25(8)DOI:. PMID:. IF:8.200(Q1/1D).
01/08/2025 Dietary patterns and exposure to non-persistent endocrine-disrupting chemicals during pregnancy
Warkentin, S, Márquez, S, Vespalcová, H, Knox, B, Gascon, M, Güil-Oumrait, N, González-Palacios, S, Roig, MDG, Lassale, C, Llurba, E, Rolland, M, Sakhi, AK, Thomsen, C, Vioque, J, Bustamante, M, Sunyer, J, Vrijheid, M. Dietary patterns and exposure to non-persistent endocrine-disrupting chemicals during pregnancy. ENVIRONMENT INTERNATIONAL. 2025; 202DOI:10.1016/j.envint.2025.109612. PMID:40578114. IF:9.700(Q1/1D).
01/08/2025 Protocol: Scoping review of the association between complementary feeding, growth, and immune health in infants and toddlers-An EAACI guideline paper
Venter, C, Alonso-Coello, P, Beltran, J, Bracchiglione, J, Fernandez-Saenz, K, Riera, P, Solà, I, Arasi, S, Canani, RB, Fleischer, D, Eguiluz-Gracia, I, Meyer, R, Roberts, G, Roth-Walter, F, Santos, AF, Skypala, I, Smith, PK, Sokolowska, M, Torres, MJ, Vassilopoulou, E, Walter, J, O'Mahony, L. Protocol: Scoping review of the association between complementary feeding, growth, and immune health in infants and toddlers-An EAACI guideline paper. PEDIATRIC ALLERGY AND IMMUNOLOGY. 2025; 36(8)DOI:10.1111/pai.70145. PMID:40747578. IF:4.500(Q1/1D).
01/08/2025 Stromal Cells, Extracellular Matrix Components, and Adenosine A3 Receptor in Prostate Biopsies: Association With Histological Grade, PSA Levels, and Clinical Tumor Stage
Pérez-Barraza, N, Acuña, P, San Martín, S, Varas, J, Cordova, C, Casalino, R, Madrid, E. Stromal Cells, Extracellular Matrix Components, and Adenosine A3 Receptor in Prostate Biopsies: Association With Histological Grade, PSA Levels, and Clinical Tumor Stage. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY. 2025; 73(7-8)DOI:10.1369/00221554251349873. PMID:40682346. IF:1.500(Q4/10D).
01/08/2025 Preoperative estimated glomerular filtration rate to predict cardiac events in major noncardiac surgery
Mases, A, de Heredia, SB, Sabaté, S. Preoperative estimated glomerular filtration rate to predict cardiac events in major noncardiac surgery. BRITISH JOURNAL OF ANAESTHESIA. 2025; 135(2)DOI:10.1016/j.bja.2025.04.040. PMID:40447484. IF:9.200(Q1/1D).
01/08/2025 Evolution of tuberculosis in Spain: Will the objectives of the End TB Strategy be achieved in Western European countries?
Rodrigo, T, Millet, JP, Bravo, M, Tabernero, EM, Caylá, JA. Evolution of tuberculosis in Spain: Will the objectives of the End TB Strategy be achieved in Western European countries?. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2025; 43(7)DOI:10.1016/j.eimc.2025.02.004. PMID:. IF:2.500(Q2/5D).
01/08/2025 Practices of low value or unnecessary practices in vascular prevention Document of the Spanish Interdisciplinary Committee for Vascular Prevention
Brotons, C, Moral, I, Abajo, JMG, Mendivelso, JC, Rico, OC, Díaz, A, Elosua, R, Pardo, DE, Guerrero, MMF, Fondado, MG, Gorostidi, M, Canino, MMG, Grau, M, Herraiz, CG, Lahoz, C, Martínez, ELC, Rivas, NMO, Ortega, E, Pallarés-Carratalá, V, Rodilla, E, Royo-Bordonada, MA, Febres, LMS, Olmo, RS, Torres-Fonseca, MM, Velescu, A, Zamora, A, Armario, P. Practices of low value or unnecessary practices in vascular prevention Document of the Spanish Interdisciplinary Committee for Vascular Prevention. Hipertension Y Riesgo Vascular. 2025; 42(3)DOI:10.1016/j.hipert.2025.01.002. PMID:39956741. IF:(Q/D).
01/08/2025 Grant-of-use cooperative housing and its relation with health and wellbeing: A conceptual framework
Reyes, A, Novoa, AM, Borrell, C, Carrere, J, Pérez, K, Gamboa, C, Daví, L, Fernández, A. Grant-of-use cooperative housing and its relation with health and wellbeing: A conceptual framework. CITIES. 2025; 163DOI:10.1016/j.cities.2025.106066. PMID:. IF:6.600(Q1/1D).
01/08/2025 Spatial Bayesian distributed lag non-linear models with R-INLA
Quijal-Zamorano, M, Martinez-Beneito, MA, Ballester, J, Marí-Dell'Olmo, M. Spatial Bayesian distributed lag non-linear models with R-INLA. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 2025; 54(4)DOI:10.1093/ije/dyaf120. PMID:40694830. IF:5.900(Q1/1D).
01/08/2025 Role of emergency departments in HIV screening in Barcelona (Spain) and impact of a targeted opt-in strategy for HIV testing
Carbó, M, Miró, E, Hurtado, JC, Avila, A, Robert, N, Rivas, GF, Llaneras, J, Segura, AR, Guardiola, JM, Miró, E, Sentis, L, del Castillo, JG, Gené, E, Miró, O. Role of emergency departments in HIV screening in Barcelona (Spain) and impact of a targeted opt-in strategy for HIV testing. European Journal of Emergency Medicine. 2025; 32(4)DOI:10.1097/MEJ.0000000000001229. PMID:40557507. IF:4.200(Q1/1D).
01/08/2025 Cone beam CT dose optimisation: A review and expert consensus by the 2022 ESTRO Physics Workshop IGRT working group
Wilson, LJ, Hadjipanteli, A, Ostergaard, DE, Bogaert, E, Brown, KF, DeJong, R, Earley, J, Edouard, M, Khan, M, Lindsay, J, van der Himst, J, Ding, GX, Wood, T, Aznar, MC, Jornet, N, Ntentas, G. Cone beam CT dose optimisation: A review and expert consensus by the 2022 ESTRO Physics Workshop IGRT working group. RADIOTHERAPY AND ONCOLOGY. 2025; 209DOI:10.1016/j.radonc.2025.110958. PMID:40425073. IF:5.300(Q1/2D).
01/08/2025 Infarct-like myocarditis in adolescents: Exploring genetic insights from diagnosis through follow-up
Esmel-Vilomara, R, Riaza, L, Dolader, P, Rodríguez-Santiago, B, Lasa-Aranzasti, A, Muñoz-Cabello, P, Fernández-Alvarez, P, Figueras-Coll, M, Bianco, L, Bueno-Gómez, A, Vargas-Pons, L, Camprubí-Tubella, E, Marimon-Blanch, C, Sabaté-Rotés, A, Rosés-Noguer, F, Gran, F. Infarct-like myocarditis in adolescents: Exploring genetic insights from diagnosis through follow-up. INTERNATIONAL JOURNAL OF CARDIOLOGY. 2025; 432DOI:10.1016/j.ijcard.2025.133255. PMID:40246029. IF:3.200(Q2/3D).
01/08/2025 Efficacy of a Digitally Supported Intervention for Children and Adolescents With Difficult-to-control Asthma (INSPIRINGKIDS): Results From a Multicentre Randomized Controlled Trial
Maroto, E, Lombarte, MDE, Garriga-Baraut, T, del Cerro, GG, Caballero-Rabasco, MA, Hernández, G, Valdesoiro-Navarrete, L, Fitch, S, Sebio-Garcia, R, Messa, ID. Efficacy of a Digitally Supported Intervention for Children and Adolescents With Difficult-to-control Asthma (INSPIRINGKIDS): Results From a Multicentre Randomized Controlled Trial. ARCHIVOS DE BRONCONEUMOLOGIA. 2025; 61(8)DOI:10.1016/j.arbres.2025.04.004. PMID:40345955. IF:9.200(Q1/1D).
01/08/2025 Imaging Efficacy of [18F]CTT1057 PET/CT in Patients with Biochemically Recurrent Prostate Cancer: Results from GuidePath-A Phase 3, Prospective Multicenter Study
Fanti, S, Barba, JJR, Behr, S, Maurer, T, Paredes, P, Walz, J, Duch, J, Perdigo, MS, Mainta, IC, Bonnefoy, PB, Coulanges, M, Tang, J, Seigne, C, Wilke, C, Catafau, AM, Iagaru, A, Aggarwal, R. Imaging Efficacy of [18F]CTT1057 PET/CT in Patients with Biochemically Recurrent Prostate Cancer: Results from GuidePath-A Phase 3, Prospective Multicenter Study. JOURNAL OF NUCLEAR MEDICINE. 2025; 66(8)DOI:10.2967/jnumed.124.269266. PMID:40473464. IF:9.100(Q1/1D).
01/08/2025 Renal replacement therapy modalities and techniques in intensive care units: An international survey
Monard, C, Marel, A, Joannidis, M, Ostermann, M, Peng, ZY, Doi, K, De Rosa, S, Bobek, I, Sokolov, D, Wu, VC, Premuzic, V, Mehta, R, Bellomo, R, Garcia, X, Pizarro, C, Zarbock, A, Milet, I, Reis, T, Romain, M, Mc Nicholas, B, Schneider, A, Rimmelé, T. Renal replacement therapy modalities and techniques in intensive care units: An international survey. JOURNAL OF CRITICAL CARE. 2025; 88DOI:10.1016/j.jcrc.2025.155076. PMID:40179459. IF:2.900(Q2/4D).
01/08/2025 miR-30d-5p controls hyperhomocysteinemia-related atherosclerosis through the regulation of TIMP3 and MMP9
Griñán, R, Canyelles, M, Santos, D, Alonso, J, Mallén, A, Martínez-González, J, López, S, Martinez-Perez, A, Souto, JC, Soria, JM, Sanchez-Quesada, JL, Julve, J, Rodríguez, C, Hueso, M, Blanco-Vaca, F, Rotllan, N. miR-30d-5p controls hyperhomocysteinemia-related atherosclerosis through the regulation of TIMP3 and MMP9. ATHEROSCLEROSIS. 2025; 407DOI:. PMID:. IF:5.700(Q1/1D).
01/08/2025 ESR Bridges: next-generation imaging in prostate cancer-a multidisciplinary view
Panebianco, V, Catalano, C, Sanguedolce, F, De Santis, M, Padhani, AR. ESR Bridges: next-generation imaging in prostate cancer-a multidisciplinary view. EUROPEAN RADIOLOGY. 2025; 35(8)DOI:10.1007/s00330-025-11354-1. PMID:39890618. IF:4.700(Q1/2D).
01/08/2025 Current training landscape for novice robotic surgeons: an international investigative survey by the Junior-ERUS/Young academic urologists (YAU) robotics in urology working group
Wuernschimmel, C, Wenzel, M, Moschovas, MC, Dell'Oglio, P, Paciotti, M, Bravi, CA, De Groote, R, Di Maida, F, Piramide, F, Turri, F, Andras, I, Sorce, G, Liakos, N, Breda, A, Larcher, A. Current training landscape for novice robotic surgeons: an international investigative survey by the Junior-ERUS/Young academic urologists (YAU) robotics in urology working group. WORLD JOURNAL OF UROLOGY. 2025; 43(1)DOI:10.1007/s00345-025-05845-5. PMID:40748464. IF:2.900(Q2/3D).
01/08/2025 Key strategies for reducing recurrence in T1 bladder cancer. Evidence from a retrospective multicenter European study
Contieri, R, Guigui, A, Gondran-Tellier, B, Basile, G, Zattoni, F, Gallioli, A, Verri, P, Aumatell, J, Lechevallier, E, Bastide, C, Akiki, A, Toledano, H, Moschini, M, Amparore, D, Mertens, LS, Pradere, B, Rajwa, P, Teoh, JYC, Porpiglia, F, Breda, A, Montorsi, F, Baboudjian, M, Uleri, A. Key strategies for reducing recurrence in T1 bladder cancer. Evidence from a retrospective multicenter European study. INTERNATIONAL UROLOGY AND NEPHROLOGY. 2025; 57(8)DOI:10.1007/s11255-025-04416-2. PMID:39934553. IF:1.900(Q3/6D).
01/08/2025 Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial
Shore, ND, Powles, TB, Bedke, J, Galsky, MD, Redorta, JP, Ku, JH, Kretkowski, M, Xylinas, E, Alekseev, B, Ye, DW, Guerrero-Ramos, F, Briganti, A, Kulkarni, GS, Brinkmann, J, Calella, AM, Cesari, R, Eccleston, A, Michelon, E, Vermette, J, Wei, CM, Steinberg, GD. Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial. NATURE MEDICINE. 2025; 31(8)DOI:10.1038/s41591-025-03738-z. PMID:40450141. IF:50.000(Q1/1D).
01/08/2025 Prognostic Implications of Patients With Clinically Node Positive Bladder Cancer Undergoing Radical Cystectomy
Scilipoti, P, Moschini, M, Zaurito, P, Longoni, M, De Angelis, M, Afferi, L, Lonati, C, Tremolada, G, Viti, A, Santangelo, A, Pichler, R, Necchi, A, Montorsi, F, Briganti, A, Mari, A, Krajewski, W, Laukthina, E, Pradere, B, Del Giudice, F, Mertens, L, Gallioli, A, Soria, F, Gontero, P, Albisinni, S, Shariat, SF, Carando, R. Prognostic Implications of Patients With Clinically Node Positive Bladder Cancer Undergoing Radical Cystectomy. Clinical Genitourinary Cancer. 2025; 23(4)DOI:10.1016/j.clgc.2025.102377. PMID:40514269. IF:2.700(Q2/3D).
01/08/2025 Prostate Cancer Outcomes in Immunocompromised Patients: A Systematic Review and Meta-analysis
Sanguedolce, F, Tedde, A, Basile, G, Di Bello, F, Baboudjian, M, Uleri, A, Mancon, S, Chernysheva, D, Figuls, MR, Gallioli, A, Territo, A, Rouprêt, M, Palou, J, Breda, A. Prostate Cancer Outcomes in Immunocompromised Patients: A Systematic Review and Meta-analysis. European Urology Oncology. 2025; 8(4)DOI:10.1016/j.euo.2025.05.021. PMID:40533295. IF:9.300(Q1/1D).
01/08/2025 Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial (May, 10.1038/s41591-025-03738-z, 2025)
Shore, ND, Powles, TB, Bedke, J, Galsky, MD, Redorta, JP, Ku, JH, Kretkowski, M, Xylinas, E, Alekseev, B, Ye, DW, Guerrero-Ramos, F, Briganti, A, Kulkarni, GS, Brinkmann, J, Calella, AM, Cesari, R, Eccleston, A, Michelon, E, Vermette, J, Wei, CM, Steinberg, GD. Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial (May, 10.1038/s41591-025-03738-z, 2025). NATURE MEDICINE. 2025; 31(8)DOI:10.1038/s41591-025-03894-2. PMID:40691368. IF:50.000(Q1/1D).
01/08/2025 Patterns of failure after stereotactic body radiotherapy to non-spine bone metastases
Pérez-Montero, H, Lozano, A, de Blas, R, Hernández, J, Mera, A, Guedea, F, Navarro-Martín, A. Patterns of failure after stereotactic body radiotherapy to non-spine bone metastases. Clinical & Translational Oncology. 2025; 27(8)DOI:10.1007/s12094-025-03878-1. PMID:40009131. IF:2.500(Q3/6D).
01/08/2025 Transplantation of a healthy bone marrow into hypertriglyceridemic animals improves liver metabolism and favours cardiac healing post-myocardial infarction
Ramos-Regalado, L, Alcover, S, Padró, T, Sancho, G, Badimon, L, Balart, J, Vilahur, G. Transplantation of a healthy bone marrow into hypertriglyceridemic animals improves liver metabolism and favours cardiac healing post-myocardial infarction. ATHEROSCLEROSIS. 2025; 407DOI:. PMID:. IF:5.700(Q1/1D).
01/08/2025 Optimising antibiotic prescriptions in paediatric respiratory tract infections: a process evaluation
Arias-Alonso, L, Barragan-Brun, N, Elizondo-Alzola, U, Mas-Dalmau, G, Gonz lez-Lama, J, Alonso-Coello, P. Optimising antibiotic prescriptions in paediatric respiratory tract infections: a process evaluation. PATIENT EDUCATION AND COUNSELING. 2025; 137DOI:10.1016/j.pec.2025.108990. PMID:. IF:3.100(Q1/1D).
01/08/2025 Hypertriglyceridemia and its relationship with all-cause mortality and pancreatitis: Results from a large retrospective clinical registry
Vlacho, B, Julve, J, Genua, I, Fernández-Camins, B, Real, J, Franch-Nadal, J, Mauricio, D, Ortega, E. Hypertriglyceridemia and its relationship with all-cause mortality and pancreatitis: Results from a large retrospective clinical registry. Journal of Clinical Lipidology. 2025; 19(4)DOI:10.1016/j.jacl.2025.04.195. PMID:40467441. IF:4.600(Q1/2D).
01/08/2025 Using the Observational Medical Outcomes Partnership Common Data Model for a multi-registry intensive care unit benchmarking federated analysis: lessons learned
Rashan, A, Püttmann, DP, de Keizer, NF, Dongelmans, DA, Cornet, R, Ranzani, O, Waweru-Siika, W, Smith, M, Harris, S, Beane, A, Bakhshi-Raiez, F. Using the Observational Medical Outcomes Partnership Common Data Model for a multi-registry intensive care unit benchmarking federated analysis: lessons learned. Jamia Open. 2025; 8(4)DOI:10.1093/jamiaopen/ooaf052. PMID:40698026. IF:(Q/D).
01/08/2025 Homozygous Familial Hypercholesterolemia in Spain: Data From Registry of the Spanish Atherosclerosis Society
Sánchez-Hernández, RM, Ibarretxe, D, Jiménez, FF, Martínez-Hervás, S, Blanco-Echevarria, A, Rodríguez, BC, Rodríguez-Carnero, G, Ordiales, MMM, Pérez, A, González-Bustos, P, Armesto, RA, Sánchez-Sobrino, P, Masana, L, Civeira, F. Homozygous Familial Hypercholesterolemia in Spain: Data From Registry of the Spanish Atherosclerosis Society. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2025; 110(8)DOI:10.1210/clinem/dgae784. PMID:39514762. IF:5.100(Q1/2D).
01/08/2025 Fibrosis quantification in hidradenitis suppurativa tunnels: Histological correlation with shear wave elastography
Mateu-Arrom, L, Mozos, A, Puig, L, Vilarrasa, E. Fibrosis quantification in hidradenitis suppurativa tunnels: Histological correlation with shear wave elastography. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2025; 39(8)DOI:10.1111/jdv.20514. PMID:39699957. IF:8.000(Q1/1D).
01/08/2025 Absence of Anti-LGI4 Autoantibodies in a European Cohort of CIPD Patients
Cegarra, PL, Caballero-Avila, M, De Lorenzo, A, Lleixà, C, Collet-Vidiella, R, Martín-Aguilar, L, Pascual-Goñi, E, Querol, L. Absence of Anti-LGI4 Autoantibodies in a European Cohort of CIPD Patients. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30(3)DOI:. PMID:. IF:3.200(Q2/4D).
01/08/2025 CIDP With Anti-GM1 IgM Antibodies: A Continuum With Multifocal Motor Neuropathy
Collet-Vidiella, R, Caballero-Avila, M, Llarch, P, Tejada-Illa, C, Pascual-Goñi, E, Martín-Aguilar, L, Lleixà, C, Vesperinas, A, Carbayo-Viejo, A, Llansó, L, Rojas, R, Querol, L. CIDP With Anti-GM1 IgM Antibodies: A Continuum With Multifocal Motor Neuropathy. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30(3)DOI:. PMID:. IF:3.200(Q2/4D).
01/08/2025 Balance Assessment in Patients With Peripheral Neuropathies Using Digital Biomechanical Biomarkers
Illa, CT, Pegueroles, J, Claramunt-Molet, M, Pi-Cervera, A, Heras-Delgado, A, Gascón-Fontal, J, Idelsohn-Zielonka, S, Rico, M, Vidal, N, Martín-Aguilar, L, Caballero-Avila, M, Lleixà, C, Collet-Vidiella, R, Llarch, P, Llansó, L, Carbayo-Viejo, A, Vesperinas, A, Querol, L, Pascual-Goñi, E. Balance Assessment in Patients With Peripheral Neuropathies Using Digital Biomechanical Biomarkers. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30(3)DOI:. PMID:. IF:3.200(Q2/4D).
01/08/2025 Exploratory Biomarker Analyses in a Phase 2 Trial of Riliprubart for Chronic Inflammatory Demyelinating Polyneuropathy
Querol, L, Hourcade, S, Chow, T, Chen, Y, Levit, M, Hammond, TR, Kramer, ML, Ternes, N, Seluzhytsky, A, Alonso-Alonso, M, Atassi, N, Lewis, RA. Exploratory Biomarker Analyses in a Phase 2 Trial of Riliprubart for Chronic Inflammatory Demyelinating Polyneuropathy. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30(3)DOI:. PMID:. IF:3.200(Q2/4D).